Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections
Intravenous vancomycin is the recommended first-line therapy for serious MRSA infections, with dosing of 15-20 mg/kg every 8-12 hours and target trough concentrations of 15-20 μg/mL for severe infections. 1
Treatment Approach Based on Infection Type
Skin and Soft Tissue Infections (SSTIs)
Uncomplicated SSTIs:
- Incision and drainage is the primary treatment for purulent infections 2
- Oral options:
Complicated SSTIs:
Bacteremia and Endocarditis
- IV vancomycin for 2-6 weeks depending on complications 1
- For uncomplicated bacteremia: minimum 14 days therapy 1
- For complicated bacteremia or endocarditis: 4-6 weeks therapy 1
- Alternative options:
Pneumonia
- IV vancomycin with loading dose of 25-30 mg/kg in seriously ill patients 1, 6
- Linezolid 600 mg IV/PO twice daily (may be superior to vancomycin for MRSA pneumonia) 1, 5
Central Nervous System Infections
- Meningitis: IV vancomycin for 2 weeks 1
- Brain abscess/epidural abscess: IV vancomycin for 4-6 weeks 1
- Neurosurgical drainage is recommended when applicable 1
- Alternatives: linezolid 600 mg PO/IV twice daily or TMP-SMX 5 mg/kg/dose IV every 8-12 hours 1
Vancomycin Dosing and Monitoring
Adult Dosing
- Standard dosing: 15-20 mg/kg/dose (actual body weight) every 8-12 hours 1
- Loading dose: 25-30 mg/kg for serious infections (sepsis, meningitis, pneumonia, endocarditis) 1
- For most SSTIs with normal renal function: 1 g every 12 hours 1
Monitoring
- Trough concentrations should be obtained before the 4th or 5th dose at steady state 1
- Target trough concentrations:
- AUC/MIC ratio ≥400 is the best predictor of efficacy 7, 8
Pediatric Dosing
- IV vancomycin 15 mg/kg/dose every 6 hours for serious infections 1
- Target trough concentrations of 15-20 μg/mL for serious infections 1
Treatment Failure Considerations
- For isolates with vancomycin MIC >2 μg/mL, use alternative agents 1
- If no clinical or microbiological response to vancomycin despite adequate debridement, switch to alternative agent regardless of MIC 1
- Consider surgical intervention for deep-seated infections 1
Special Considerations
- Pregnancy: Avoid TMP-SMX in third trimester 2
- Renal impairment: Adjust vancomycin dosing based on renal function 1
- Children <2 months: Avoid TMP-SMX 2
- Obese patients: Use actual body weight for initial dosing calculations 1
Prevention of MRSA Infections
- Standard precautions including hand hygiene
- Keep draining wounds covered with clean, dry bandages
- Avoid sharing personal items
- For recurrent infections, consider decolonization with mupirocin (nasal) and chlorhexidine (body) 2
Common Pitfalls to Avoid
Underdosing vancomycin: Traditional dosing of 1g every 12 hours often fails to achieve target trough concentrations, especially in critically ill patients 6, 9
Relying solely on MIC without considering AUC/MIC ratio: The therapeutic effectiveness of vancomycin is best described by AUC/MIC ratio rather than trough concentration alone 7, 8
Failure to obtain cultures before starting antibiotics: Culture results guide definitive therapy 2
Inadequate surgical intervention: Many treatment failures with deep-seated infections occur due to lack of necessary surgical intervention 1
Not adjusting therapy based on clinical response: If no improvement is seen despite adequate vancomycin therapy, consider alternative agents 1